Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy

[1]  M. Landray,et al.  Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. , 2016, The lancet. Diabetes & endocrinology.

[2]  F. Dekker,et al.  The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  A. Davenport,et al.  UK Renal Registry 18th Annual Report: Appendix H Coding: Ethnicity, EDTA Primary Renal Diagnoses, EDTA Causes of Death , 2016, Nephron.

[4]  B. Lacey,et al.  Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. , 2016, Circulation research.

[5]  Gavin Yamey,et al.  Avoiding 40% of the premature deaths in each country, 2010–30: review of national mortality trends to help quantify the UN Sustainable Development Goal for health , 2015, The Lancet.

[6]  R. MacLehose,et al.  Estimating predicted probabilities from logistic regression: different methods correspond to different target populations. , 2014, International journal of epidemiology.

[7]  C. van Walraven,et al.  Survival trends in ESRD patients compared with the general population in the United States. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  M. Campbell,et al.  Variation in centre-specific survival in patients starting renal replacement therapy in England is explained by enhanced comorbidity information from hospitalization data. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  K. Mahaffey,et al.  Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. , 2012, The New England journal of medicine.

[10]  Sumi J. Sun,et al.  A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  A. Dawnay,et al.  Appendix H: Coding: Ethnicity, EDTA Primary Renal Diagnoses, EDTA Causes of Death , 2011, Nephron Clinical Practice.

[12]  K. Polkinghorne,et al.  Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  R. Collins,et al.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[14]  L. Reynolds,et al.  History of Dialysis in the UK: c.1950-1980 , 2009 .

[15]  H. Tighiouart,et al.  Key comorbid conditions that are predictive of survival among hemodialysis patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[16]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[17]  R. Fluck,et al.  A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  L. Mauri,et al.  The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. , 2006, American heart journal.

[19]  P. Morris.  Transplantation--a medical miracle of the 20th century. , 2004, The New England journal of medicine.

[20]  David W. Johnson,et al.  Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. , 2004, Journal of the American Society of Nephrology : JASN.

[21]  A. Cass,et al.  Cause of death in patients with end‐stage renal disease: assessing concordance of death certificates with registry reports , 2003, Australian and New Zealand journal of public health.

[22]  Francesco Locatelli,et al.  Effect of dialysis dose and membrane flux in maintenance hemodialysis. , 2003, The New England journal of medicine.

[23]  Nancy Fink,et al.  The Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality , 2002, Annals of Internal Medicine.

[24]  S. Davies,et al.  Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  M. Rocco,et al.  Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  V Seagroatt,et al.  Use of large medical databases to study associations between diseases. , 2000, QJM : monthly journal of the Association of Physicians.

[27]  Eld,et al.  COMPARISON OF MORTALITY IN ALL PATIENTS ON DIALYSIS , PATIENTS ON DIALYSIS AWAITING TRANSPLANTATION , AND RECIPIENTS OF A FIRST CADAVERIC TRANSPLANT , 2000 .

[28]  Avid,et al.  THE EFFECTS OF NORMAL AS COMPARED WITH LOW HEMATOCRIT VALUES IN PATIENTS WITH CARDIAC DISEASE WHO ARE RECEIVING HEMODIALYSIS AND EPOETIN , 2000 .

[29]  M. Brescia,et al.  The early development of the arteriovenous fistula needle technique for hemodialysis. , 1994, ASAIO journal.

[30]  P. Whelton,et al.  Cause of death in patients with end-stage renal disease: death certificates vs registry reports. , 1993, American journal of public health.

[31]  I. Khan,et al.  Influence of coexisting disease on survival on renal-replacement therapy , 1993, The Lancet.

[32]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[33]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[34]  P. Ratcliffe,et al.  Late referral for maintenance dialysis. , 1984, British medical journal.

[35]  P. Koenig.  Intermittent Haemodialysis , 1966, British medical journal.

[36]  E D Acheson,et al.  The Oxford Record Linkage Study: A Review of the Method with Some Preliminary Results , 1964, Proceedings of the Royal Society of Medicine.